GC
ADPT icon

Guggenheim Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Guggenheim Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,497
Closed -$256K – 1587
2025
Q1 		$256K Sell
34,497
-6,348
-16% -$48.8K ﹤0.01% 1457
2024
Q4 		$245K Sell
40,845
-10,093
-20% -$55.6K ﹤0.01% 1520
2024
Q3 		$261K Sell
50,938
-2,390
-4% -$10.4K ﹤0.01% 1668
2024
Q2 		$193K Sell
53,328
-1,547
-3% -$4.91K ﹤0.01% 1768
2024
Q1 		$176K Sell
54,875
-1,974
-3% -$7.64K ﹤0.01% 1811
2023
Q4 		$279K Sell
56,849
-351
-0.6% -$1.6K ﹤0.01% 1701
2023
Q3 		$312K Buy
57,200
+30,754
+116% +$203K ﹤0.01% 1609
2023
Q2 		$177K Buy
26,446
+15,306
+137% +$114K ﹤0.01% 1791
2023
Q1 		$98.4K Buy
+11,140
New +$98.2K ﹤0.01% 1878
2022
Q4 		– Sell
-18,605
Closed -$132K – 1910
2022
Q3 		$132K Sell
18,605
-978
-5% -$9.21K ﹤0.01% 1829
2022
Q2 		$158K Buy
19,583
+880
+5% +$7.74K ﹤0.01% 1976
2022
Q1 		$260K Buy
18,703
+68
+0.4% +$1.07K ﹤0.01% 1944
2021
Q4 		$523K Sell
18,635
-52,384
-74% -$1.61M ﹤0.01% 1674
2021
Q3 		$2.41M Sell
71,019
-2,847
-4% -$103K 0.01% 964
2021
Q2 		$3.02M Buy
73,866
+810
+1% +$31.5K 0.02% 882
2021
Q1 		$2.94M Buy
73,056
+17,132
+31% +$927K 0.02% 833
2020
Q4 		$3.31M Buy
+55,924
New +$2.88M 0.02% 752

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guggenheim Capital's ADPT Position: Q2 2025 in Review

Guggenheim Capital sold out of Adaptive Biotechnologies (ADPT) in Q2 2025, closing a stake of 34,497 shares — an estimated $256K sold.

Guggenheim Capital first reported a position in ADPT in Q4 2020 and held it in 17 quarters. The position peaked at $3.31M in Q4 2020. 242 funds tracked by Wall St. Rank hold ADPT as of Q2 2025.

  • Guggenheim Capital reported no remaining Adaptive Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • Guggenheim Capital sold 34,497 Adaptive Biotechnologies shares in Q2 2025, an estimated $256K.
  • Guggenheim Capital first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 17 quarters.
  • Guggenheim Capital's Adaptive Biotechnologies position peaked at $3.31M in Q4 2020.
  • 242 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2025.

Based on Guggenheim Capital's 13F filing for Q2 2025, filed 13 Aug 2025.